Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical hold
Biotech
FDA puts partial hold on BioNTech-OncoC4 phase 3 trial
The FDA has implemented a partial hold on a phase 3 NSCLC trial run by BioNTech and OncoC4 after seeing varying results among patients.
Gabrielle Masson
Oct 18, 2024 12:55pm
FDA puts Novavax's phase 3 plan on hold for pair of vaccines
Oct 16, 2024 9:10am
FDA places Kezar lupus trial in hold following 4 patient deaths
Oct 7, 2024 5:50am
FDA lifts diabetes hold after Biomea mitigates liver tox risk
Sep 27, 2024 7:10am
FDA allows BioNTech-MediLink ADC trial to resume at lower doses
Aug 19, 2024 8:45am
Stoke's Dravet syndrome med released of partial clinical hold
Aug 7, 2024 8:54am
